Biophytis, a French age-related medical drug developer backed by Seventure Partners and CM-CIC Partners, is aiming to raise €19.9m with its upcoming listing on Alternext.
Danish VC Heartcore Capital, UVC Partners and existing investor Picus Capital also take part
Deal is an extension of the $4.1m series-A funding round led by Blossom Capital in October 2019
Fresh capital will help the provider of cloud access services expand in western Europe
DBay has also negotiated a new revolving credit facility for the transport and logistics company